Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Li Xiao Rui
The Human Equilibrative Nucleoside Transporter Protein1 (Hent1) Is a Predict /Prognostic Factor in Resected Pancreatic Cancer Patients
Biomedical Journal of Scientific & Technical Research
Related publications
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated With Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Chimeric Constructs Between Human and Rat Equilibrative Nucleoside Transporters (hENT1 and rENT1) Reveal hENT1 Structural Domains Interacting With Coronary Vasoactive Drugs
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Mutation of Leucine-92 Selectively Reduces the Apparent Affinity of Inosine, Guanosine, NBMPR [S6-(4-Nitrobenzyl)-Mercaptopurine Riboside] and Dilazep for the Human Equilibrative Nucleoside Transporter, hENT1
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Genomic Analysis of Nucleoside Transporters in Diptera and Functional Characterization ofDmENT2, a Drosophila Equilibrative Nucleoside Transporter
Physiological Genomics
Genetics
Physiology
Mutation of Trp29of Human Equilibrative Nucleoside Transporter 1 Alters Affinity for Coronary Vasodilator Drugs and Nucleoside Selectivity
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
The Anatomic Location of Pancreatic Cancer Is a Prognostic Factor for Survival
HPB
Hepatology
Gastroenterology
Analysis of Interleukin-13 Receptor Alpha2 Expression as a Prognostic Biomarker in Surgically Resected Pancreatic Cancer Patients
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology